News
Glaxosmithkline Pharmaceuticals consolidated net profit rises 1.98% in the September 2025 quarter
06-Nov-2025 | 17:11
Sales decline 3.05% to Rs 979.94 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 1.98% to Rs 257.49 crore in the quarter ended September 2025 as against Rs 252.50 crore during the previous quarter ended September 2024. Sales declined 3.05% to Rs 979.94 crore in the quarter ended September 2025 as against Rs 1010.77 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended | ||
| Sep. 2025 | Sep. 2024 | % Var. | |
| Sales | 979.94 | 1010.77 | -3 |
| OPM % | 34.26 | 31.83 | - |
| PBDT | 368.79 | 355.98 | 4 |
| PBT | 351.36 | 339.12 | 4 |
| NP | 257.49 | 252.50 | 2 |
Powered by Capital Market - Live News